Skip to main content

Advertisement

SpringerLink
Log in

Bioterrorism and the nervous system

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Recent events of war, terrorist attacks, and mail-borne anthrax exposure have produced increasing awareness of potential bioterrorism attacks in the United States and other parts of the world. Physicians and healthcare personnel play a key role in identifying potential bioterrorist attacks. Early recognition and preparedness for bioterrorism-associated illnesses is especially important for neurologists because most bioterrorism agents can directly or indirectly affect the nervous system. This article reviews the neurologic manifestations, diagnosis, and treatments of syndromes caused by potential bioterrorism agents, as well as the potential side effects of vaccines against some of these agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. History of Bioterrorism: http://bcrc.bio.umass.edu/phpwiki/ index.php/HistoryOfBioterrorism. Accessed on June 1, 2002.

  2. History of Biowarfare: http://www.usamriid.army.mil/education/ bluebook.html. Accessed on June 1, 2002.

  3. Bioterrorism preparedness and response program: http:// www.bt.cdc.gov/index.asp. Accessed on June 1, 2002.

  4. Suffin SC, Carnes WH, Kauffman AF: Inhalation anthrax in a home craftsman. Hum Pathol 1978, 9:594–597.

    PubMed  CAS  Google Scholar 

  5. Update: Investigation of bioterrorism-related anthrax, 2001. Morb Mortal Wkly Rep 2001, 50:1008–1010.

  6. Franz DR, Jahrling PB, McClain DJ, et al.: Clinical recognition and management of patients exposed to biological warfare agents. Clin Lab Med 2001, 21:435–473.

    PubMed  CAS  Google Scholar 

  7. Lanska DJ: Anthrax meningoencephalitis. Neurology 2002, 59:327–334. A thorough review of anthrax meningoencephalitis, including clinical manifestations, diagnosis and treatment, and outcomes.

    PubMed  Google Scholar 

  8. Abramova FA, Grinberg LM, Yampolskaya OV, Walker DH: Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci U S A 1993, 90:2291–2294.

    Article  PubMed  CAS  Google Scholar 

  9. Jernigan JA, Stephens DS, Ashford DA, et al.: Bioterrorismrelated inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 2001, 7:933–944.

    Article  PubMed  CAS  Google Scholar 

  10. Haight TH: Anthrax meningitis: review of literature and report of two cases with autopsies. Am J Med Sci 1952, 224:57–69.

    Article  PubMed  CAS  Google Scholar 

  11. Tabatabaie P, Syadati A: Bacillus anthracis as a cause of bacterial meningitis. Pediatr Infect Dis J 1993, 12:1035–1037.

    Article  PubMed  CAS  Google Scholar 

  12. Kim HJ, Jun WB, Lee SH, Rho MH: CT and MR findings of anthrax meningoencephalitis: report of two cases and review of the literature. Am J Neuroradiol 2001, 22:1303–1305.

    PubMed  CAS  Google Scholar 

  13. Pluot M, Vital C, Aubertin J, et al.: Anthrax meningitis. Report of two cases with autopsies. Acta Neuropathol (Berl) 1976, 36:339–345.

    Article  CAS  Google Scholar 

  14. Penn CC, Klotz SA: Anthrax pneumonia. Semin Respir Infect 1997, 12:28–30.

    PubMed  CAS  Google Scholar 

  15. Bell DM, Kozarsky PE, Stephens DS: Clinical issues in the prophylaxis, diagnosis, and treatment of anthrax. Emerg Infect Dis 2002, 8:222–225.

    Article  PubMed  Google Scholar 

  16. Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. Morb Mortal Wkly Rep 2001, 50:941–948.

  17. Nass M: The Anthrax Vaccine Program: an analysis of the CDC’s recommendations for vaccine use. Am J Public Health 2002, 92:715–721.

    Article  PubMed  Google Scholar 

  18. Use of anthrax vaccine in the United States. MMWR Recomm Rep 2000, 49:1–20.

  19. Kerrison JB, Lounsbury D, Thirkill CE, et al.: Optic neuritis after anthrax vaccination. Ophthalmology 2002, 109:99–104.

    Article  PubMed  Google Scholar 

  20. Jenner E: An inquiry into the causes and effects of the variolae vacciniae, a disease discovered in some of the western counties of England, particularly Gloucestershire, and known by the name of cowpox. London: Samson Low, 1798.

    Google Scholar 

  21. Fenner F, Henderson DA, Arita I, et al.: Smallpox and Its Eradication. Geneva: World Health Organization; 1988.

    Google Scholar 

  22. Alibek K: Biohazard. New York: Random House, 1999.

    Google Scholar 

  23. Downie AW, Meiklejohn M, St Vincent L, et al.: The recovery of smallpox virus from patients and their environment in a smallpox hospital. Bull World Health Org 1965, 33:615–622.

    PubMed  CAS  Google Scholar 

  24. Cleri DJ, Villota FJ, Porwancher RB: Smallpox, bioterrorism, and the neurologist. Arch Neurol 2003, 60:489–494. A complete review of the neurologic manifestations of smallpox. In addition, the authors list potential complications of the smallpox vaccine and enumerate arguments for and against mass reintroduction of the smallpox vaccine.

    Article  PubMed  Google Scholar 

  25. Borio L, Inglesby T, Peters CJ, et al.: Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 2002, 287:2391–2405.

    Article  PubMed  Google Scholar 

  26. Marsden JP, Hurst EW: Acute perivascular myelinoclasis in smallpox. Brain 1932, 55:181–225.

    Article  Google Scholar 

  27. Ropp SL, Jin Q, Knight JC, et al.: PCR strategy for identification and differentiation of small pox and other orthopoxviruses. J Clin Microbiol 1995, 33:2069–2076.

    PubMed  CAS  Google Scholar 

  28. Bartlett J, Borio L, Radonovich L, et al.: Smallpox vaccination in 2003: key information for clinicians. Clin Infect Dis 2003, 36:883–902.

    Article  PubMed  Google Scholar 

  29. Roos KL, Eckerman NL: The smallpox vaccine and postvaccinal encephalitis. Semin Neurol 2002, 22:95–98.

    Article  PubMed  Google Scholar 

  30. Cardiac adverse events following smallpox vaccination--United States, 2003. Morb Mortal Wkly Rep 2003, 52:248–250.

  31. Inglesby TV, Dennis DT, Henderson DA, et al.: Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 2000, 283:2281–2290. A consensus statement from the Working Group on Civilian Biodefense, this paper covers all aspects of bioterrorist attack using plague from clinical syndromes (laboratory diagnosis and treatment to prophylaxis). Consensus statements from this Working Group cover other bioterrorism agents.

    Article  PubMed  CAS  Google Scholar 

  32. Harris SH: Factories of Death. New York: Routledge, 1994.

    Google Scholar 

  33. Becker TM, Poland JD, Quan TJ, et al.: Plague meningitis—a retrospective analysis of cases reported in the United States, 1970–1979. West J Med 1987, 147:554–557.

    PubMed  CAS  Google Scholar 

  34. Butler T: Yersinia species (including plague). In Principles and Practice of Infectious Diseases. Edited by Dolin T. New York: Churchill Livingstone; 1995: 2070–2078.

    Google Scholar 

  35. MacDonald KL, Cohen ML, Blake PA: The changing epidemiology of adult botulism in the United States. Am J Epidemiol 1986, 124:794–799.

    PubMed  CAS  Google Scholar 

  36. Weber JT, Hibbs RG Jr, Darwish A, et al.: A massive outbreak of type E botulism associated with traditional salted fish in Cairo. J Infect Dis 1993, 167:451–454.

    PubMed  CAS  Google Scholar 

  37. Hughes JM, Blumenthal JR, Merson MH, et al.: Clinical features of types A and B food-borne botulism. Ann Intern Med 1981, 95:442–445.

    PubMed  CAS  Google Scholar 

  38. United States Public Health Services: Botulism in the United States, 1899–1973: Handbook for Epidemiologists, Clinicians and Laboratory Workers. Atlanta: US Dept. of Health, Education and Welfare; 1974.

    Google Scholar 

  39. Woodruff BA, Griffin PM, McCroskey LM, et al.: Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States, 1975–1988. J Infect Dis 1992, 166:1281–1286.

    PubMed  CAS  Google Scholar 

  40. Beck CG, Wyckof RW: Venezuelan equine encephalitis. Science 1938, 88:530.

    Article  PubMed  CAS  Google Scholar 

  41. Johnson KM, Martin DH: Venezuelan equine encephalitis. Adv Vet Sci Comp Med 1974, 18:79–116.

    PubMed  CAS  Google Scholar 

  42. Coates DM, Makh SR, Jones N, Lloyd G: Assessment of assays for the serodiagnosis of Venezuelan equine encephalitis. J Infect 1992, 25:279–289.

    Article  PubMed  CAS  Google Scholar 

  43. Corbel MJ: Brucellosis: epidemiology and prevalence worldwide. In Brucellosis: Clinical and Laboratory Aspects. Edited by Corbel MJ. Boca Raton, FL: CRC Press; 1989:25–40.

    Google Scholar 

  44. Buchanan TM, Hendricks SL, Patton CM, Feldman RA: Brucellosis in the United States, 1960–1972; an abattoir-associated disease. Part III. Epidemiology and evidence for acquired immunity. Medicine 1974, 53:427–439.

    Article  PubMed  CAS  Google Scholar 

  45. Lulu AR, Araj GF, Khateeb MI, et al.: Human brucellosis in Kuwait: a prospective study of 400 cases. Q J Med 1988, 66:39–54.

    PubMed  CAS  Google Scholar 

  46. Mousa AR, Elhag KM, Khogali M, Marafie AA: The nature of human brucellosis in Kuwait: study of 379 cases. Rev Infect Dis 1988, 10:211–217.

    PubMed  CAS  Google Scholar 

  47. Shakir RA, Al-Din AS, Araj GF, et al.: Clinical categories of neurobrucellosis. A report on 19 cases. Brain 1987, 110:213–223.

    Article  PubMed  Google Scholar 

  48. Larbrisseau A, Maravi E, Aguilera F, Martinez-Lage JM: The neurological complications of brucellosis. Can J Neurol Sci 1978, 5:369–376.

    PubMed  CAS  Google Scholar 

  49. McLean DR, Russell N, Khan MY: Neurobrucellosis: clinical and therapeutic features. Clin Infect Dis 1992, 15:582–590.

    PubMed  CAS  Google Scholar 

  50. Ferguson NE, Steele L, Crawford CY, et al.: Bioterrorism web site resources for infectious disease clinicians and epidemiologists. Clin Infect Dis 2003, 36:1458–1473. An exhaustive list of web sites concerning bioterrorism.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Harborview Medical Center, 325 Ninth Avenue South, Box 359775, 98104, Seattle, WA, USA

    M. H. Han MD & J. R. Zunt MD, MPH

Authors
  1. M. H. Han MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. R. Zunt MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Han, M.H., Zunt, J.R. Bioterrorism and the nervous system. Curr Neurol Neurosci Rep 3, 476–482 (2003). https://doi.org/10.1007/s11910-003-0050-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-003-0050-9

Keywords

Search

Navigation